Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Rosuvastatin with Clopidogrel in Acute Ischemic Stroke
NCT06360120Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Apr 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin, rosuvastatin in ischemic stroke, sponsored by Kafrelsheikh University. Started Apr 2024; status: recruiting.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06360120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06360120.